Progenics Pharmaceuticals

Progenics Pharmaceuticals
Public
Traded as NASDAQ: PGNX
Industry Healthcare
Headquarters 777 Old Saw Mill River Road, Tarrytown, New York, United States
Key people
Peter J. Crowley (Chairman)
Mark Robert Baker (Chief Executive Officer)
Products Biopharmaceuticals
Website progenics.com

Progenics Pharmaceuticals is an American biopharmaceutical corporation. It is listed on the NASDAQ.[1][2] It creates and sells medicine for HIV, Hepatitis C, and cancer.[1]

References

  1. 1 2 "Progenics Pharmaceuticals Inc". Bloomberg Business. Retrieved November 6, 2015.
  2. "Progenics Pharmaceuticals Inc.". MarketWatch. Retrieved November 6, 2015.
This article is issued from Wikipedia - version of the 11/6/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.